 |
||||||
 |
 |
 |
||||
 |
|
 |
||||
|
|
 |
 |
 |
 |
|
||||||||||||||||||||||||||||||||||||||||
|
Communications and other activitiesCommunication presented on March 23, 2010 (Thematic Meeting : "Fertility and Gynecologic cancer")
Contraceptive methods after gynecological and breast cancer Contraceptive methods after gynecological and breast cancer Key-words (Index medicus) :
Bernard BLANC*, *** , Alexandre LAZARD**, Jean-Philippe ESTRADE***, Aubert AGOSTINI**, Brice GURRIET***
SUMMARY
With earlier diagnosis and more effective treatments, more and more women are receiving fertility-preserving cancer therapy. Approximately 10 % of breast and gynecological cancers occur in women under 40, and more than 5 000 French women under 45 develop breast cancer each year. While hormonal contraception is contra-indicated for women with a history of breast or endometrial cancer, it seems to have a protective effective in ovarian cancer. Although pregnancy is not contra-indicated after cancer, it must be planned in a timely manner, meaning that appropriate contraception is necessary in the meantime.
**Service de gynécologie Obstétrique, Hôpital de la Conception, 147 boulevard Baille, 13385 Marseille, France ***Hôpital Ambroise Paré, 1 rue d'Eylau, 13006 Marseille, France
26/03/2010
Back to the list |
 |
|
|
||||||||||||||||||||||||||||||||||||||||||
|
|
 |
 |
|
|
 |
|
 |
 |
 |
|
||